New study investigates hidden heart risk in liver patients

NCT ID NCT07658222

Recruiting now Knowledge-focused Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study looks at a heart condition called cirrhotic cardiomyopathy that can affect people with advanced liver disease (cirrhosis). Researchers want to learn how common it is, what increases the risk, and whether bile acids in the blood play a role. About 440 adults with decompensated cirrhosis will be followed at two medical centers in the U.S. to track their heart and liver health over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify risk factors and mechanisms for cirrhotic cardiomyopathy, pointing toward future treatments or monitoring strategies.
What could go wrong: This is an observational study, not a treatment trial, so it will not directly benefit participants. It is early-stage research, and findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOTIC CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure cirrhotic cardiomyopathy Fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOTIC CARDIOMYOPATHY

Contacts and locations

Locations

UT Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.